Literature DB >> 1420376

Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.

M J Avery1, D Y Mitchell, F C Falkner, H G Fouda.   

Abstract

A specific high-performance liquid chromatographic/atmospheric pressure chemical ionization tandem mass spectrometric assay for the quantitative determination of tenidap and its D3 analog in human serum is described. The assay exhibited a linear dynamic range of 0.1-25 micrograms ml-1. Its precision for the two analytes over the range was 17% or better. The assay validity and its utility to investigate changes in tenidap bioequivalence and pharmacokinetics are presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420376     DOI: 10.1002/bms.1200210706

Source DB:  PubMed          Journal:  Biol Mass Spectrom        ISSN: 1052-9306


  4 in total

1.  A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients.

Authors:  L Evans; L Aarons; P Coates
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

2.  Effect of high-performance liquid chromatography mobile phase components on sensitivity in negative atmospheric pressure chemical ionization liquid chromatography-mass spectrometry.

Authors:  W H Schaefercor; F Dixon
Journal:  J Am Soc Mass Spectrom       Date:  1996-10       Impact factor: 3.109

3.  Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.

Authors:  M J Gardner; K D Wilner; R A Hansen; H G Fouda; G F McMahon
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

4.  Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma.

Authors:  W W Bullen; R A Miller; R N Hayes
Journal:  J Am Soc Mass Spectrom       Date:  1999-01       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.